Purification, amino acid sequences and assay cross-reactivities of porcine insulin-like growth factor-I and -II

in Journal of Endocrinology
Authors:
G. L. Francis
Search for other papers by G. L. Francis in
Current site
Google Scholar
PubMed
Close
,
P. C. Owens
Search for other papers by P. C. Owens in
Current site
Google Scholar
PubMed
Close
,
K. A. McNeil
Search for other papers by K. A. McNeil in
Current site
Google Scholar
PubMed
Close
,
J. C. Wallace
Search for other papers by J. C. Wallace in
Current site
Google Scholar
PubMed
Close
, and
F. J. Ballard
Search for other papers by F. J. Ballard in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

ABSTRACT

Porcine insulin-like growth factor-I (IGF-I) and IGF-II have been characterized to help define the roles of these peptides in the growth process. The amino acid sequence of porcine IGF-I was found to be identical to the human and bovine peptides. Porcine IGF-II was more similar to human IGF-II than to forms of this growth factor in other mammalian species, differing only in the replacement of asparagine for serine at residue 36. In a biological assay that measures the stimulation of protein synthesis in rat L6 myoblasts, porcine IGF-I was approximately ninefold more potent than porcine IGF-II or bovine IGF-II, while recombinant human IGF-I and IGF-II had half the potency of the respective natural peptides. Porcine and recombinant human IGF-I showed essentially equal competition for binding in a human IGF-I radioimmunoassay while between 0·6 and 1·5% cross-reactivity was observed with human, bovine or porcine IGF-II. A receptor assay for IGF-II demonstrated similar potencies for the three IGF-II peptides, while the cross-reactivity of recombinant human IGF-I was only 0·05%. Porcine IGF-I exhibited a higher cross-reactivity, presumably due to very slight contamination with IGF-II.

Journal of Endocrinology (1989) 122, 681–687

 

  • Collapse
  • Expand